These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28900817)

  • 1. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.
    Polimeni L; Pastori D; Baratta F; Tozzi G; Novo M; Vicinanza R; Troisi G; Pannitteri G; Ceci F; Scardella L; Violi F; Angelico F; Del Ben M
    Intern Emerg Med; 2017 Dec; 12(8):1159-1165. PubMed ID: 28900817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
    Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
    World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.
    Baratta F; Pastori D; Del Ben M; Polimeni L; Labbadia G; Di Santo S; Piemonte F; Tozzi G; Violi F; Angelico F
    EBioMedicine; 2015 Jul; 2(7):750-4. PubMed ID: 26288848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients.
    Selvakumar PK; Kabbany MN; Lopez R; Tozzi G; Alisi A; Alkhouri N; Nobili V
    Dig Liver Dis; 2016 Aug; 48(8):909-13. PubMed ID: 27198736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
    Ferri F; Mischitelli M; Tozzi G; Messina E; Mignini I; Mazzuca S; Pellone M; Parisse S; Marrapodi R; Visentini M; Baratta F; Del Ben M; Pastori D; Perciballi R; Attilia ML; Carbone M; De Santis A; Violi F; Angelico F; Ginanni Corradini S
    Clin Transl Gastroenterol; 2020 Feb; 11(2):e00116. PubMed ID: 32463622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.
    Tovoli F; Napoli L; Negrini G; D'Addato S; Tozzi G; D'Amico J; Piscaglia F; Bolondi L
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease.
    Shteyer E; Villenchik R; Mahamid M; Nator N; Safadi R
    Int J Mol Sci; 2016 Feb; 17(3):312. PubMed ID: 26927097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
    Baratta F; Pastori D; Tozzi G; D'Erasmo L; Di Costanzo A; Arca M; Ettorre E; Ginanni Corradini S; Violi F; Angelico F; Del Ben M
    Liver Int; 2019 Dec; 39(12):2301-2308. PubMed ID: 31392821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
    Angelico F; Corradini SG; Pastori D; Fargion S; Fracanzani AL; Angelico M; Bolondi L; Tozzi G; Pujatti PL; Labbadia G; Corazza GR; Averna M; Perticone F; Croce G; Persico M; Bucci T; Baratta F; Polimeni L; Del Ben M; Violi F;
    Atherosclerosis; 2017 Jul; 262():179-184. PubMed ID: 28396038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures.
    Gomaraschi M; Fracanzani AL; Dongiovanni P; Pavanello C; Giorgio E; Da Dalt L; Norata GD; Calabresi L; Consonni D; Lombardi R; Branchi A; Fargion S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158523. PubMed ID: 31505261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
    Baratta F; Pastori D; Polimeni L; Tozzi G; Violi F; Angelico F; Del Ben M
    Int J Mol Sci; 2015 Nov; 16(12):28014-21. PubMed ID: 26602919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
    Gravito-Soares M; Gravito-Soares E; Gomes D; Tome L
    Ann Hepatol; 2019; 18(1):78-88. PubMed ID: 31113613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot.
    Vespasiani-Gentilucci U; D'Amico J; De Vincentis A; Tozzi G; Vorini F; Gallo P; Carotti S; Valentini F; Galati G; dell'Unto C; Piemonte F; Picardi A
    Clin Biochem; 2017 Aug; 50(12):726-728. PubMed ID: 28238812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.
    Thoen RU; Longo L; Neto SC; Álvares-da-Silva MR
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101638. PubMed ID: 33662773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2.
    Hamilton J; Jones I; Srivastava R; Galloway P
    Clin Chim Acta; 2012 Aug; 413(15-16):1207-10. PubMed ID: 22483793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.
    Carotti S; Lettieri-Barbato D; Piemonte F; Ruggiero S; Rosina M; Zalfa F; Zingariello M; Arciprete F; Valentini F; Francesconi M; D'Amico J; De Vincentis A; Baiocchini A; Perrone G; Antonelli-Incalzi R; Morini S; Picardi A; Aquilano K; Vespasiani-Gentilucci U
    Cell Death Dis; 2021 Nov; 12(12):1092. PubMed ID: 34795230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal Acid Lipase Activity in Non-alcoholic Fatty Liver Disease as a Novel Diagnostic and Therapeutic Target: A Systematic Literature Review of Current Evidence and Future Directions.
    Bashir A; Duseja A; Verma A; De A; Tiwari P
    J Clin Exp Hepatol; 2022; 12(6):1535-1546. PubMed ID: 36340307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease.
    Dairaku T; Iwamoto T; Nishimura M; Endo M; Ohashi T; Eto Y
    Mol Genet Metab; 2014 Feb; 111(2):193-6. PubMed ID: 24295952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
    Bradić I; Liesinger L; Kuentzel KB; Vujić N; Trauner M; Birner-Gruenberger R; Kratky D
    J Lipid Res; 2023 Sep; 64(9):100427. PubMed ID: 37595802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.